Holen Sie sich die Stockscreener-App
0.00
100.00%
-0.6063
Schlusskurs vom Vortag:
$0.6063
Offen:
$0
24-Stunden-Volumen:
0
Relative Volume:
0.00
Marktkapitalisierung:
$82.91M
Einnahmen:
$247.99M
Nettoeinkommen (Verlust:
$-521.97M
KGV:
0.00
EPS:
-1.11
Netto-Cashflow:
$-194.28M
1W Leistung:
-100.00%
1M Leistung:
-100.00%
6M Leistung:
-100.00%
1J Leistung:
-100.00%
1-Tages-Spanne:
$0.00
$0.00
1-Wochen-Bereich:
$0.00
$0.00
52-Wochen-Spanne:
$0.00
$10.81
23 Andme Holding Co Stock (ME) Company Profile
Firmenname
23 Andme Holding Co
Sektor
Branche
Telefon
(650) 938-6300
Adresse
223 N. MATHILDA AVE., SUNNYVALE
Vergleichen Sie ME mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ME
23 Andme Holding Co
|
0.00 | 82.91M | 247.99M | -521.97M | -194.28M | -1.11 |
|
TMO
Thermo Fisher Scientific Inc
|
429.33 | 156.49B | 42.90B | 6.52B | 6.72B | 17.05 |
|
DHR
Danaher Corp
|
203.20 | 145.01B | 23.82B | 3.77B | 4.90B | 5.15 |
|
IDXX
Idexx Laboratories Inc
|
547.01 | 42.30B | 3.93B | 894.97M | 837.70M | 10.82 |
|
A
Agilent Technologies Inc
|
121.38 | 34.24B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
164.24 | 27.64B | 15.50B | 1.33B | 2.16B | 7.34 |
23 Andme Holding Co Stock (ME) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2022-11-29 | Eingeleitet | Berenberg | Buy |
| 2022-09-22 | Eingeleitet | Cowen | Outperform |
| 2021-11-15 | Herabstufung | Citigroup | Buy → Neutral |
| 2021-08-17 | Eingeleitet | Credit Suisse | Outperform |
| 2021-07-12 | Eingeleitet | Citigroup | Buy |
23 Andme Holding Co Aktie (ME) Neueste Nachrichten
23andMe Seeks To Ease Concerns Over Sale To Founder - Law360
23andMe Bankruptcy Judge Rejects Texas Effort to Halt Data Sale - Bloomberg Law News
DNA testing firm 23andMe fined £2.31m for ‘serious security failings’ - MSN
23andMe fined millions by watchdog after ‘profoundly damaging’ cyber attack exposing genetic data - lbc.co.uk
Anne Wojcicki on genetic privacy, data security and the money behind her bid for 23andMe - The Business Journals
23andMe Fined £2.31 Million by UK Over Genetic Data Leak - Bloomberg
23andMe Names New Buyer, Pa. Retirees Sue Over Ch. 9 Sale - Law360
23andme founder-led group outbids Regeneron for company - BioWorld MedTech
Regeneron declines to make higher bid for 23andMe after Wojcicki's $305 million offer - Reuters
Regeneron Pharmaceuticals says declined to submit new bid on 23andMe exceeding original $256 mln - MarketScreener
23andMe co-founder Anne Wojcicki regains control of bankrupt genetic testing company - AllSides
23andMe co-founder Anne Wojcicki wins back genetic test company in bankruptcy court saleBizwomen - The Business Journals
23andMe Holding Acquired by TTAM Research Institute - TipRanks
23andMe Founder's $305M Bid Buys Back Co. In Ch. 11 Sale - Law360
23andMe (MEHCQ) Acquired by TTAM for $305M - GuruFocus
23andMe Co-Founder Wins Auction for Genetic Data - Bloomberg
23andMe's founder Anne Wojcicki wins bid for bankrupt DNA testing firm - MarketScreener
23andMe sold to non-profit headed by co-founder Anne Wojcicki - Seeking Alpha
Anne Wojcicki wins back 23andMe in bankruptcy court saleSan Francisco Business Times - The Business Journals
23andMe confirms sale of business to TTAM Research Institute for $305M - TipRanks
23andMe's founder Anne Wojcicki wins bid for DNA testing firm - marketscreener.com
23andMe assets to be sold to founder’s nonprofit for $305 million - Investing.com
23andMe Reaches Agreement for Sale of Business to TTAM - GlobeNewswire
Anne Wojcicki Wins Bidding For 23Andme- WSJ - marketscreener.com
23andMe Ombudsman Not Confident Sale Is Lawful - Law360
Ocasio-Cortez leads congressional call for genetic data safeguards amid 23andMe bankruptcy - Bronx Times
23andMe Privacy Ombudsman Urges User Consent Pre-Data Sale (1) - Bloomberg Law News
Senate holds hearing on 23andMe, concerns over company selling customers’ data (Video) - Social News XYZ
Congress Grills 23andMe on Data Privacy as States Take Legal Action Over Company Sale - The HIPAA Journal
IP, Health Law Scholars Object To 23andMe Ch. 11 Data Sale - Law360
23andme genetic privacy concerns garner Congressional scrutiny - BioWorld MedTech
23andMe Holding Co. SEC 10-K Report - TradingView
Senator Calls For 23AndMe Customers To Sue Company 'Into Oblivion' - Newsweek
Senate holds hearing on 23andMe, concerns over company selling customers' data - CBS News
States Sue To Block 23andMe From Selling DNA Data In Ch. 11 - Law360
23andMe (MEHCQ) Faces Legal Challenge Over Genetic Data Sale - GuruFocus
23andMe Privacy Reviewer’s Law Firm Discloses Work for Regeneron - Bloomberg Law News
US states sue 23andMe to protect customers' private data - marketscreener.com
23andMe sued by state attorneys general over plans to sell genetic data - Seeking Alpha
New York AG sues 23andMe to protect customers' private data - marketscreener.com
23andMe’s Proposed Bankruptcy Sale Prompts States’ Challenge (1) - Bloomberg Law News
23andMe seeks second auction as ex-CEO outbids Regeneron - MSN
Senator calls for 23AndMe customers to sue company "into oblivion" - MSN
23andMe Reopens Bidding, Jackson Walker Mediates Fee Suit - Law360
Millennium Management LLC Has $720,000 Holdings in 23andMe Holding Co. (NASDAQ:ME) - Defense World
The New Twist In Regeneron's 23andMe Bankruptcy Buyout - Investor's Business Daily
Bankruptcy Was Good for 23andMe - Bloomberg.com
23andMe Sets New Auction With $305 Million New Bid From Ex-CEO - Bloomberg
23andMe’s DNA Data Soars in Value With New $305 Million Bid - MSN
23andMe (MEHCQ) Faces Second Auction as Former CEO Bids $305M - GuruFocus
23andMe’s DNA data gets boosted $305m bid in new auction - Moneyweb
Finanzdaten der 23 Andme Holding Co-Aktie (ME)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.18%
0.48%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):